​
​

Lyell Immunopharma (LYEL) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Lyell Immunopharma Revenue Highlights

Latest Revenue (Y)

$130.00K

Latest Revenue (Q)

$34.00K

Lyell Immunopharma Revenue by Period

Lyell Immunopharma Revenue by Year

DateRevenueChange
2023-12-31$130.00K-99.85%
2022-12-31$84.68M695.15%
2021-12-31$10.65M37.31%
2020-12-31$7.76M1080.52%
2019-12-31$657.00K-

Lyell Immunopharma generated $130.00K in revenue during NA 2023, up -99.85% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Lyell Immunopharma Revenue by Quarter

DateRevenueChange
2024-09-30$34.00K161.54%
2024-06-30$13.00K333.33%
2024-03-31$3.00K-76.92%
2023-12-31$13.00K-48.00%
2023-09-30$25.00K-7.41%
2023-06-30$27.00K-58.46%
2023-03-31$65.00K34.34%
2022-12-31$48.39K1512.87%
2022-09-30$3.00K-99.99%
2022-06-30$35.74M6363.11%
2022-03-31$553.00K-80.40%
2021-12-31$2.82M2.43%
2021-09-30$2.75M4.83%
2021-06-30$2.63M7.48%
2021-03-31$2.44M5.75%
2020-12-31$2.31M116.07%
2020-09-30$1.07M-65.68%
2020-06-30$3.12M148.25%
2020-03-31$1.26M-

Lyell Immunopharma generated $34.00K in revenue during Q3 2024, up 161.54% compared to the previous quarter, and up 125.93% compared to the same period a year ago.

Lyell Immunopharma Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
MRUSMerus$43.95M$11.77M
RVMDRevolution Medicines, Inc. Warrant$11.58M-
KRONKronos Bio$6.29M$2.37M
GBIOGeneration Bio$5.90M$4.09M
CRNXCrinetics Pharmaceuticals$4.01M-
IPSCCentury Therapeutics$2.23M$791.00K
INBXInhibrx Biosciences$1.80M-
STTKShattuck Labs$1.66M$1.61M
LYELLyell Immunopharma$130.00K$34.00K
CGEMCullinan Oncology--
CCCCC4 Therapeutics--
NKTXNkarta--
MLYSMineralys Therapeutics--
SANASana Bio--
GLUEMonte Rosa Therapeutics-$4.70M
EWTXEdgewise Therapeutics--
NUVBNuvation Bio-$727.00K

LYEL Revenue FAQ

What is Lyell Immunopharma’s yearly revenue?

Lyell Immunopharma's yearly revenue for 2023 was $130K, representing a decrease of -99.85% compared to 2022. The company's yearly revenue for 2022 was $84.68M, representing an increase of 695.15% compared to 2021. LYEL's yearly revenue for 2021 was $10.65M, representing an increase of 37.31% compared to 2020.

What is Lyell Immunopharma’s quarterly revenue?

Lyell Immunopharma's quarterly revenue for Q3 2024 was $34K, a 161.54% increase from the previous quarter (Q2 2024), and a 36.00% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $13K, a 333.33% increase from the previous quarter (Q1 2024), and a -51.85% decrease year-over-year (Q2 2023). LYEL's quarterly revenue for Q1 2024 was $3K, a -76.92% decrease from the previous quarter (Q4 2023), and a -95.38% decrease year-over-year (Q1 2023).

What is Lyell Immunopharma’s revenue growth rate?

Lyell Immunopharma's revenue growth rate for the last 3 years (2021-2023) was -98.78%, and for the last 5 years (2019-2023) was -80.21%.